Next Article in Journal
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System
Next Article in Special Issue
Ketamine’s Role in Neuroinflammation and Neuroprotection Across Neurological and Psychiatric Disorders: A Narrative Review
Previous Article in Journal
Synthesis and Application of Silver Nanoparticles for Caries Management: A Review
Previous Article in Special Issue
Mechanisms of NMDA Receptor Inhibition by Biguanide Compounds
 
 
Review

Article Versions Notes

Pharmaceuticals 2024, 17(10), 1265; https://doi.org/10.3390/ph17101265
Action Date Notes Link
article html file updated 4 January 2026 05:59 CET Update https://www.mdpi.com/1424-8247/17/10/1265/html
article html file updated 13 September 2025 20:25 CEST Update -
article html file updated 25 August 2025 01:58 CEST Update -
article html file updated 27 June 2025 00:09 CEST Update -
article html file updated 25 September 2024 17:13 CEST Original file -
article pdf uploaded. 25 September 2024 17:11 CEST Version of Record https://www.mdpi.com/1424-8247/17/10/1265/pdf
article xml uploaded. 25 September 2024 17:11 CEST Update https://www.mdpi.com/1424-8247/17/10/1265/xml
article xml file uploaded 25 September 2024 17:11 CEST Original file -
Back to TopTop